FUNDAMENTALS |
MarketCap: |
4.78 mill
|
EPS: |
-3.13
|
P/E: |
-0.0100
|
Earnings Date: |
May 13, 2024 |
SharesOutstanding: |
122.68 mill
|
Avg Daily Volume: |
28.31 mill
|
RATING
2024-04-26 |
C+
|
Sell
|
RATINGS |
Rating CashFlow: |
Strong Sell
|
|
Return On Equity: |
Strong Sell
|
|
Return On Asset: |
Sell
|
|
DE: |
Buy
|
|
P/E: |
Neutral
|
|
Price To Book: |
Sell
|
|
QUARTER GROWTHS |
|
3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 |
Revenue | | | | | | |
Gr.Profit | | | | | | |
Ebit | | | | | | |
Asset | | | | | | |
Debt | | | | | | |
PE RATIO: COMPANY / SECTOR |
0.00x
|
Company: PE -0.0100 | sector: PE -3.05
|
PE RATIO: COMPANY / INDUSTRY |
0.00x
|
Company: PE -0.0100 | industry: PE 222.16
|
DISCOUNTED CASH FLOW VALUE |
N/A
|
N/A
|
Expected Trading Range (DAY) |
$ 0.0259 - 0.0519
( +/- 33.42%)
|
ATR Model: 14 days
|
Insider Trading
Date |
Person |
Action |
Amount |
type |
2022-11-29 | Truetzel David W. | Sell | 67 | Common stock |
2020-08-27 | O'brien David Francis | Buy | 269 | Common Stock |
2020-08-25 | O'brien David Francis | Buy | 5 477 | Common Stock |
2015-01-07 | O'brien David Francis | Sell | 7 | Stock Option* |
2014-03-03 | O'brien David Francis | Sell | 10 | Stock Option* |
INSIDER POWER |
-100.00
|
Last
100 transactions |
Buy:
4 995 599 | Sell:
10 978 045 |
Forecast:
14:01 - $0.0390
Live Trading Signals (every 1 min)
Forecast
1: 12:31 - $0.0390
Forecast 2: 13:21 - $0.0390
Forecast 3: 14:01 - $0.0390
SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals |
RSI 21 |
|
SMA |
|
Trend |
|
Trend 2 |
|
Trend 3 |
|
MACD |
|
Volume Signals |
Price |
$0.0390 (6.58% )
|
Volume |
14.18 mill
|
Avg. Vol. |
28.31 mill
|
% of Avg. Vol |
50.10 %
|
Signal 1: |
|
Signal 2: |
|
Last 10 Buy & Sell Signals For SINT
0 Signals |
Accuracy: 0.00% | Accuracy
Buy: 0.00% | Accuracy
Sell: 0.00%
Avg return
buy: 0.00 % | Avg return
sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
Sintx Technologies, Inc., an advanced materials company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, industrial, and antipathogenic applications primarily in the United States. The company provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.